His revenues and his price target both seem short to me. I still have hopes for $160 million sales in 2014, and much higher in 2015. Either I am putting too much emphasis on this new CMS ruling, or Bruce isn't putting enough.
Apparently he's reluctant to add Amniofix sales until FDA approval is recieved. I don't believe we'll be around in 2015.
I had talked a friend into buying a couple of months ago. He was bemoaning the the fact that he had written call options on half his position which called away last week.. The good news is he paid for a new car with his gain and option premium. He's now repurchased the shares at a signifcant premium to his original shares and is now a "true believer".